Dubai, February 2026 — During the highly anticipated WHX Labs exhibition in Dubai, B&E Bio-Tech successfully hosted the "B&E 2026 Global Distributor Conference · Dubai Station." Key distributor representatives from over ten countries across Asia, Africa, and Latin America gathered together to witness the milestone moment of B&E's 25th anniversary and outline a new blueprint for global market cooperation.

Reviewing 25 Years of Dedication, Strengthening the Foundation for Globalization

At the beginning of the conference, all guests jointly reviewed the company's 25-year journey since its inception. From its humble beginnings to its current presence with products sold in more than 90 countries and regions worldwide, B&E has always adhered to a path driven by technological innovation and guided by clinical needs. In recent years, the company has achieved remarkable results in new product R&D and international market development, not only further refining its in-vitro diagnostic product line but also establishing a stable sales network in multiple emerging markets.

Moment of Glory: 25th Anniversary Commemorative Trophy Honors Outstanding Partners

B&E's global development is inseparable from every distributor partner who has journeyed alongside. The conference featured a special awards session, presenting the "B&E 25th Anniversary Commemorative Trophy" to distributors who have made outstanding contributions to market expansion and brand building over the years. This honor is not only an affirmation of past achievements but also an expression of expectation for deepening cooperation and mutual growth in the future.

New Product Launch: Three Major Products Make a Stunning Debut

The core highlight of the conference was the in-depth presentation of three highly competitive new products:

• Handheld Blood Gas Analyzer: With core advantages of "compact portability, simplified operation, and results in 60 seconds," it provides a mobile, portable, rapid, and reliable blood gas testing solution for medical scenarios such as emergency rooms, ICUs, and operating theaters, redefining the efficiency of blood gas analysis.

• Electrolyte Testing Module with Integrated Biosensor Technology: Equipped with independently developed biosensor technology, this module achieves seamless integration with compact biochemical instruments, saving laboratory space and significantly enhancing automation levels and workflow efficiency.

• High-Speed Glycohemoglobin Analyzer: Leveraging the core technology of High-Performance Liquid Chromatography, it offers the combined advantages of high throughput, accurate results, and low maintenance costs, providing a reliable tool for diabetes screening and chronic disease management.

Distributors at the meeting expressed strong interest in these new products, generally agreeing that they precisely align with the global trend of clinical testing shifting towards "precision, immediacy, and intelligence," indicating immense market potential.

Peer Sharing: Inspiring Mutual Growth

During the outstanding distributor experience sharing session, the speech by the distributor representative from Iran drew enthusiastic responses from the audience. Leveraging the excellent quality and unique biosensor technology advantages of B&E's CBS electrolyte series, this team successfully entered dozens of high-end hospitals and authoritative laboratories in Iran within just one year, achieving a leap from "zero breakthrough" to "regional benchmark." The representative emphasized, "B&E not only provides products but also offers trustworthy technical support and long-term value. We look forward to introducing more new products so that Iranian users can simultaneously enjoy the world's leading testing technology."

Embarking on a New Journey: Creating Value for Global Users through Localized Deep Cultivation

The conference concluded in a warm and congenial atmosphere. Through this Dubai meeting, B&E not only conveyed its firm confidence in deeply cultivating the IVD field to global partners but also demonstrated its robust R&D and translation capabilities through the centralized debut of new products.

Moving forward, B&E will continue to uphold the philosophy of "Precise Testing, Excellent Quality," joining hands with global distributors to empower medical terminals worldwide with a more competitive product portfolio and more agile localized services, creating greater clinical and social value for users around the globe.